Genitourinary infection: Difference between revisions
No edit summary |
No edit summary |
||
| Line 9: | Line 9: | ||
**Development of symptoms 1-6mo after tx | **Development of symptoms 1-6mo after tx | ||
**Usually due to a different organism | **Usually due to a different organism | ||
**If pt has >3 recurrences in 1 yr consider tumor, calculi, | **If pt has >3 recurrences in 1 yr consider tumor, calculi, [[diabetes]] | ||
*Men <50 yr: symptoms of dysuria or urinary frequency usually due to STI | *Men <50 yr: symptoms of dysuria or urinary frequency usually due to [[STI]] | ||
*Men >50 yr: incidence of UTI rises dramatically d/t prostatic obstruction | *Men >50 yr: incidence of UTI rises dramatically d/t prostatic obstruction | ||
*Uncomplicated UTI: | *Uncomplicated UTI: | ||
| Line 24: | Line 24: | ||
##Nephrolithiasis, neurogenic bladder, polycystic renal disease, recent instrumentation | ##Nephrolithiasis, neurogenic bladder, polycystic renal disease, recent instrumentation | ||
#Recurrent UTI (three or more per year) | #Recurrent UTI (three or more per year) | ||
#Advanced age in men (BPH, recent instrumentation, recent prostatic biopsy) | #Advanced age in men ([[BPH]], recent instrumentation, recent prostatic biopsy) | ||
#Nursing home residency (w/ or w/o indwelling bladder catheter) | #Nursing home residency (w/ or w/o indwelling bladder catheter) | ||
#Neonatal state | #Neonatal state | ||
#Comorbidities (DM, sickle cell disease) | #Comorbidities ([[DM]], sickle cell disease) | ||
#Pregnancy | #Pregnancy | ||
#Immunosuppression (AIDS, immunosuppressive drugs) | #Immunosuppression ([[AIDS]], immunosuppressive drugs) | ||
#Advanced neurologic disease (CVA w/ disability, | #Advanced neurologic disease ([[CVA]] w/ disability, [[Spinal Cord Injuries]]) | ||
#Known or suspected atypical pathogens (Non–E. coli infection) | #Known or suspected atypical pathogens (Non–E. coli infection) | ||
#Known or suspected abx resistance (resistance to | #Known or suspected abx resistance (resistance to Cipro predicts multidrug resistance) | ||
===Bacteriology=== | ===Bacteriology=== | ||
*Most common pathogen is E. coli | *Most common pathogen is E. coli | ||
| Line 41: | Line 41: | ||
===Clinical Features=== | ===Clinical Features=== | ||
*UTI dx requires both bacteriuria and clinical symptoms | *UTI dx requires both bacteriuria and clinical symptoms | ||
**Cystitis = Dysuria, hematuria, frequency, urgency, suprapubic pain, CVAT | **Cystitis = Dysuria, [[hematuria]], frequency, urgency, suprapubic pain, CVAT | ||
**Pyelo = Cystitis sx AND fever/chills/nausea/vomiting | **Pyelo = Cystitis sx AND fever/chills/nausea/vomiting | ||
***CVAT alone may be referred pain from cystitis | ***CVAT alone may be referred pain from cystitis | ||
***CVAT is only physical examination finding that increases likelihood of a UTI | ***CVAT is only physical examination finding that increases likelihood of a UTI | ||
*Urethritis | *Urethritis | ||
**In males more likely due to | **In males more likely due to [[chlamydia]]/[[GC]] | ||
**In females more likely due to chlam/GC if: | **In females more likely due to [[chlam]]/[[GC]] if: | ||
***Stuttering urination symptoms | ***Stuttering urination symptoms | ||
***New sex partner or partner w/ urethritis | ***New sex partner or partner w/ urethritis | ||
| Line 53: | Line 53: | ||
***Sterile pyuria | ***Sterile pyuria | ||
*Complicated UTI | *Complicated UTI | ||
**Pts may not have classic symptoms; may only have weakness, fever, abd pain, AMS | **Pts may not have classic symptoms; may only have [[weakness]], [[fever]], [[abd pain]], [[AMS]] | ||
===Labs=== | ===Labs=== | ||
====UA==== | ====UA==== | ||
| Line 61: | Line 61: | ||
***False negative may be due to: dilute urine, systemic leukopenia, obstruction | ***False negative may be due to: dilute urine, systemic leukopenia, obstruction | ||
**WBC 1-2 w/ bacteriuria can be significant in men | **WBC 1-2 w/ bacteriuria can be significant in men | ||
***More likely represents urethritis or prostatitis from STI | ***More likely represents [[urethritis]] or [[prostatitis]] from [[STI]] | ||
=====Nitrite===== | =====Nitrite===== | ||
*Very high specificity (>90%) in confirming diagnosis of UTI | *Very high specificity (>90%) in confirming diagnosis of UTI | ||
*Low sensitivity (enterococcus, pseudomonas, acinetobacter are not detected) | *Low sensitivity (enterococcus, pseudomonas, acinetobacter are not detected) | ||
====Urine Culture==== | ====[[Urine Culture]]==== | ||
*Indicated for: | *Indicated for: | ||
**Complicated UTI | **Complicated UTI | ||
| Line 73: | Line 73: | ||
**Adult males | **Adult males | ||
**Relapse/reinfection | **Relapse/reinfection | ||
====Blood Culture==== | ====[[Blood Culture]]==== | ||
*Not indicated | *Not indicated | ||
**Organisms in blood cx matched those in urine cx 97% of time | **Organisms in blood cx matched those in urine cx 97% of time | ||
===Imaging=== | ===Imaging=== | ||
*Consider if pyelonephritis and any of the following: | *Consider if [[pyelonephritis]] and any of the following: | ||
#History of | #History of [[Renal Stone]] | ||
#Poor response to | #Poor response to [[antibiotics]] | ||
#Male | #Male | ||
#Elderly | #Elderly | ||
#Diabetic | #[[Diabetic]] | ||
#Severely ill | #Severely ill | ||
== | ==Management== | ||
*Consider local resistance patterns (if >10-20% use a different agent) | *Consider local resistance patterns (if >10-20% use a different agent) | ||
*Avoid use of fluoroquinolones for uncomplicated cystitis if possible | *Avoid use of fluoroquinolones for uncomplicated cystitis if possible | ||
*Consider longer course of tx for uncomplicated cystitis if: | *Consider longer course of tx for uncomplicated cystitis if: | ||
**Symptoms >7d | **Symptoms >7d | ||
**DM | **[[DM]] | ||
**UTI in previous 4wk | **UTI in previous 4wk | ||
**Men | **Men | ||
| Line 112: | Line 112: | ||
##GC resistance to fluoroquinolones is increasing | ##GC resistance to fluoroquinolones is increasing | ||
===Men, cystitis/pyelo=== | ===Men, cystitis/pyelo=== | ||
*Consider urethritis and prostatitis | *Consider [[urethritis]] and [[prostatitis]] | ||
#Ciprofloxacin 500mg BID x10-14d OR | #Ciprofloxacin 500mg BID x10-14d OR | ||
#Cefpodoxime 200 mg BID x10-14d | #Cefpodoxime 200 mg BID x10-14d | ||
| Line 134: | Line 134: | ||
**Consider if young, otherwise healthy, tolerating PO | **Consider if young, otherwise healthy, tolerating PO | ||
*Admission | *Admission | ||
**Consider if elderly, | **Consider if elderly, [[Renal Calculi]], obstruction, recent hospitalization/instrumentation, [[DM]] | ||
==Complications== | ==Complications== | ||
*Suspect in pts who have inadequate or atypical response to tx for presumed | *Suspect in pts who have inadequate or atypical response to tx for presumed [[pyelonephritis]] | ||
#Acute bacterial nephritis | #Acute bacterial nephritis | ||
##CT shows ill-defined focal areas of decreased density | ##CT shows ill-defined focal areas of decreased density | ||
#Renal/Perinephric | #Renal/[[Perinephric Abscesses]] | ||
##Sign/symptoms similar to pyelo (fever, CVAT, dysuria) | ##Sign/symptoms similar to [[pyelo]] ([[fever]], CVAT, dysuria) | ||
##Occurs in setting of ascending infection w/ obstructed pyelo | ##Occurs in setting of ascending infection w/ obstructed pyelo | ||
##Associated w/ DM and | ##Associated w/ [[DM]] and [[Renal Stones]] | ||
##Also occurs due to bacteremia w/ hematogenous seeding (Staph) | ##Also occurs due to bacteremia w/ hematogenous seeding (Staph) | ||
#Emphysematous pyelonephritis | #Emphysematous pyelonephritis | ||
##Rare gas-forming infection nearly always occurring in pts w/ DM and obstruction | ##Rare gas-forming infection nearly always occurring in pts w/ [[DM]] and obstruction | ||
###Pts appear toxic and septic; nephrectomy may be required | ###Pts appear toxic and [[septic]]; nephrectomy may be required | ||
==Special Populations== | ==Special Populations== | ||
===AIDS=== | ===[[AIDS]]=== | ||
*TMP-SMX resistance is increased due to its use in PCP PNA prophylaxis | *TMP-SMX resistance is increased due to its use in PCP PNA prophylaxis | ||
**Fluoroquinolones should be initial antibiotic of choice | **Fluoroquinolones should be initial antibiotic of choice | ||
Revision as of 13:01, 7 January 2014
Background
Definitions
- UTI = significant bacteriuria in presence of symptoms
- Described by location: urethritis, cystitis, or pyelonephritis
- Relapse
- Recurrence of symptoms w/in month despite tx
- Caused by same organism and represents treatment failure
- Recurrence of symptoms w/in month despite tx
- Reinfection
- Development of symptoms 1-6mo after tx
- Usually due to a different organism
- If pt has >3 recurrences in 1 yr consider tumor, calculi, diabetes
- Men <50 yr: symptoms of dysuria or urinary frequency usually due to STI
- Men >50 yr: incidence of UTI rises dramatically d/t prostatic obstruction
- Uncomplicated UTI:
- No structural or functional abnormalities w/in urinary tract or kidney
- No relevant comorbidities that place pt at risk for more serious adverse outcome
- Not associated with GU tract instrumentation
Risk factors for complicated UTI
- Male sex
- In young males dysuria is more commonly d/t STI
- Suspect underlying anatomic abnormality in men with culture-proven UTI
- Anatomic abnormality of urinary tract or external drainage system
- Indwelling urinary catheter, stent
- Nephrolithiasis, neurogenic bladder, polycystic renal disease, recent instrumentation
- Recurrent UTI (three or more per year)
- Advanced age in men (BPH, recent instrumentation, recent prostatic biopsy)
- Nursing home residency (w/ or w/o indwelling bladder catheter)
- Neonatal state
- Comorbidities (DM, sickle cell disease)
- Pregnancy
- Immunosuppression (AIDS, immunosuppressive drugs)
- Advanced neurologic disease (CVA w/ disability, Spinal Cord Injuries)
- Known or suspected atypical pathogens (Non–E. coli infection)
- Known or suspected abx resistance (resistance to Cipro predicts multidrug resistance)
Bacteriology
- Most common pathogen is E. coli
- Anaerobic organisms are rarely pathogenic (do not grow well in urine)
- Complicated UTIs more likely to be caused by pseudomonas or enterococcus
Diagnosis
Clinical Features
- UTI dx requires both bacteriuria and clinical symptoms
- Cystitis = Dysuria, hematuria, frequency, urgency, suprapubic pain, CVAT
- Pyelo = Cystitis sx AND fever/chills/nausea/vomiting
- CVAT alone may be referred pain from cystitis
- CVAT is only physical examination finding that increases likelihood of a UTI
- Urethritis
- Complicated UTI
Labs
UA
WBC count
- WBC >5 in pt w/ appropriate symptoms is diagnostic
- Lower degrees of pyuria may still be clinically significant in presence of UTI sx
- False negative may be due to: dilute urine, systemic leukopenia, obstruction
- WBC 1-2 w/ bacteriuria can be significant in men
- More likely represents urethritis or prostatitis from STI
- Lower degrees of pyuria may still be clinically significant in presence of UTI sx
Nitrite
- Very high specificity (>90%) in confirming diagnosis of UTI
- Low sensitivity (enterococcus, pseudomonas, acinetobacter are not detected)
Urine Culture
- Indicated for:
- Complicated UTI
- Pyelonephritis
- Pregnant women
- Children
- Adult males
- Relapse/reinfection
Blood Culture
- Not indicated
- Organisms in blood cx matched those in urine cx 97% of time
Imaging
- Consider if pyelonephritis and any of the following:
- History of Renal Stone
- Poor response to antibiotics
- Male
- Elderly
- Diabetic
- Severely ill
Management
- Consider local resistance patterns (if >10-20% use a different agent)
- Avoid use of fluoroquinolones for uncomplicated cystitis if possible
- Consider longer course of tx for uncomplicated cystitis if:
- Symptoms >7d
- DM
- UTI in previous 4wk
- Men
- Age 65 yr
- Women who use spermicides or diaphragm
- Relapse
Women, uncomplicated cystitis
- Nonpregnant, few prior UTI episodes, symptoms <7d, no flank pain or fever
- Nitrofurantoin ER 100mg BID x 5d OR
- TMP-SMX DS (160/800mg) 1 tab BID x 3d OR
- Cephalexin 250mg QID x 5d OR
- Ciprofloxacin 250mg BID x3d
Women, complicated cystitis/pyelo
- Risks for complicated UTI or symptoms of pyelo
- Ciprofloxacin 500mg BID x10-14d OR
- Cefpodoxime 200 mg BID x10-14d
Women, uncomplicated cystitis AND urethritis
- CTX 250mg IM x1 AND azithromycin 1gm PO x1 AND nitrofurantoin ER 100mg BID x5d OR
- Levofloxacin 500mg QD x 14d (covers UTI pathogens, GC, and chlam)
- GC resistance to fluoroquinolones is increasing
Men, cystitis/pyelo
- Consider urethritis and prostatitis
- Ciprofloxacin 500mg BID x10-14d OR
- Cefpodoxime 200 mg BID x10-14d
Inpatient
- Ciprofloxacin 400mg IV q12hr OR
- Ceftriaxone 1gm IV QD OR
- Cefotaxime 1-2gm IV q8hr OR
- Gentamicin 3mg/kg/day divided q8hr +/- ampicillin 1–2 gm q4hr OR
- Piperacillin-tazobactam 3.375 gm IV q6hr OR
- Cefepime 2gm IV q8hr OR
- Imipenem 500mg IV q8hr
Disposition
Uncomplicated UTI
- Admit
- Unable to tolerate PO
- Discharge
- Consider phenazopyridine 100-200mg TID after meals x2d only (bladder analgesic)
Pyelonephritis
- Discharge
- Consider if young, otherwise healthy, tolerating PO
- Admission
- Consider if elderly, Renal Calculi, obstruction, recent hospitalization/instrumentation, DM
Complications
- Suspect in pts who have inadequate or atypical response to tx for presumed pyelonephritis
- Acute bacterial nephritis
- CT shows ill-defined focal areas of decreased density
- Renal/Perinephric Abscesses
- Sign/symptoms similar to pyelo (fever, CVAT, dysuria)
- Occurs in setting of ascending infection w/ obstructed pyelo
- Associated w/ DM and Renal Stones
- Also occurs due to bacteremia w/ hematogenous seeding (Staph)
- Emphysematous pyelonephritis
Special Populations
AIDS
- TMP-SMX resistance is increased due to its use in PCP PNA prophylaxis
- Fluoroquinolones should be initial antibiotic of choice
- Most UTIs are caused by typical pathogens or common STI organisms
Pregnant Women
- Treat all cases of asymptomatic bacteriuria
See Also
Source
Tintinalli
